Evaluate the Bioavailability Between 2 BMS-986141 Formulations in Healthy Participants

A Randomized Study to Evaluate the Bioavailability of BMS-986141 From a Form B Tablet Formulation Relative to the Form A Reference Tablet in Healthy Participants

Open label, randomized, 4-period crossover study with single doses of BMS-986141 given to healthy female subjects of non-childbearing potential and healthy males.

Inclusion Criteria:

• Healthy participants as determined by no significant deviations in normal medical and surgical history and assessments
• Body mass index 18.0 kg/m2 to 32.0 kg/m2
• females must be of non-childbearing potential

Exclusion Criteria:

• known bleeding or coagulation disorders
• acute or chronic medical illness
• history of nausea or chronic diarrhea that lasts over 4 weeks
• history of periodontal disease or gingivitis which required treatment
• other exclusion criteria may apply